I feel that I have been able to prove beyond any doubt that MHRA’s advice to government to ban Co-proxamol was in order to increase their income and NOT FOR DRUG SAFETY CONCERNS OR EFFICACY!
Dextropropoxyphene based products are back in production in India and on the market at a very completive price, £1.13 /100 tablets
MHRA’s scare tactics were totally responsible for the scandalous price increases (£49.50) when the product was finally removed from the NHS prescribing list. For this reason the ‘Named Patient Facility’ should be reinstated immediately and the suitability for controlled status for general use. Co-proxamol should be considered to be far safer than Tramadol, Oxycodone, Fentanyl, and Buprenorphine Which MHRA have issued 298 additional ‘Marketing Authorisations’ since the ban on Co-proxamol was announced in 2005!
It should also be noted that there was a total lack of ‘due diligence’ by ministers when they decided to accept MHRA’s seriously flawed recommendations regarding Co-proxamol.
Ministers Directly Responsible For the Lack of Due Diligence
Patricia Hewitt 5 May 2005 – 27 June 2007
Alan Johnson Secretary of State for Health Jun 2007 - Jun 2009
Caroline Flint Minister for Public Health from 2005 to 2007
Dawn Primarolo Minister for Public Health 2007–2009
Secretary of State for Health Jeremy Hunt, my MP Paul Maynard, PrescQIPP, LMMG, CCG, DOH, and the NHS have all acted in a disgraceful manner by refusing to confront the MHRA regarding the MISSINFORMATION they have peddled since 2005; MHRA have had a complete disregard for patient’s safety and wellbeing, and the colossal increased costs which have burdened the NHS throughout this sad state of affairs!
MHRA are nothing more than a REPREHENSIBLE MONEY GRUBBING ORGANISATION IN CAHOOTS WITH BIG PHARMA and are totally devoid of a moral conscience regarding patient safety and wellbeing. They are totally responsible making life intolerable for millions of patients globally!
* Medindia Drugs Drug Price
Caybutyl (Dextropropoxyphene) Double Strength 1 Tab Max 4 Daily
100 Tabs = 97 INR = 1.13092 GBP
Indian Rupee1 INR = 0.0116590 GBP
Price List Updated on February 2nd 2017
Drug information on Caybutyl (Dextropropoxyphene) from Jagsonpal Pharmaceuticals Ltd.
Combination of Generics - Dextropropoxyphene, Paracetamol
Trade Name Caybutyl
Manufacturer Jagsonpal Pharmaceuticals Ltd.
Unit 650mg/65mg (1-4 Tablets Daily)
Brudex (400+325+32.5) (Dextropropoxyphene - Combination)
Drug information on Brudex (400+325+32.5) (Dextropropoxyphene - Combination) from PRG Pharma Pvt Ltd.
Combination of Generics - Dextropropoxyphene, Ibuprofen, Paracetamol
Trade Name Brudex (400+325+32.5)
Manufacturer PRG Pharma Pvt Ltd.
There should be hope for the Millions of patients who have been denied Co-proxamol for the past ten years!
Caybutyl is a combination prescription 650mg/65mg Paracetamol/ Dextropropoxyphene and comes as a tablet or capsule. A single tablet would be equivalent to the Co-proxamol dose of 2 x 325 /32.5mg.
I have recently been in contact with the Parliamentary Health Committee and the Ombudsman and I would appreciate anyone who has been affected by this ban to contact their GP and MP immediately as PESTER POWER MAY GET CO-PROXAMOL REINSTATED QUICKER FOR EVERYONE WHO NEEDS IT!